These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 10576777)

  • 1. Benzodiazepine receptor ligands. III. Synthesis and biological evaluation of 2- and/or 3-substituted pyrazolo[5,1-c][1,2,4]benzotriazine 5-oxides.
    Guerrini G; Costanzo A; Bruni F; Ciciani G; Selleri S; Gratteri P; Costa B; Martini C; Lucacchini A
    Farmaco; 1999 Jun; 54(6):375-89. PubMed ID: 10576777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benzodiazepine receptor ligands. 4. Synthesis and pharmacological evaluation of 3-heteroaryl-8-chloropyrazolo[5,1-c][1,2,4] benzotriazine 5-oxides.
    Costanzo A; Guerrini G; Ciciani G; Bruni F; Selleri S; Costa B; Martini C; Lucacchini A; Aiello PM; Ipponi A
    J Med Chem; 1999 Jun; 42(12):2218-26. PubMed ID: 10377227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New 2,3-substituted 4,7-dihydro-6-(1'H-pyrazol-3'-yl)pyrazolo[1,5-a] pyrimidin-7-ones and related compounds: synthesis and benzodiazepine receptor binding study.
    Selleri S; Bruni F; Costanzo A; Guerrini G; Casilli ML; Giusti L; Lucacchini A; Martini C
    Farmaco; 1995 Oct; 50(10):679-87. PubMed ID: 8590575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New fluoro derivatives of the pyrazolo[5,1-c][1,2,4]benzotriazine 5-oxide system: evaluation of fluorine binding properties in the benzodiazepine site on γ-aminobutyrric acid type A (GABA(A)) receptor. Design, synthesis, biological, and molecular modeling investigation.
    Guerrini G; Ciciani G; Bruni F; Selleri S; Guarino C; Melani F; Montali M; Daniele S; Martini C; Ghelardini C; Norcini M; Ciattini S; Costanzo A
    J Med Chem; 2010 Nov; 53(21):7532-48. PubMed ID: 20939501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benzodiazepine receptor ligands. 8: synthesis and pharmacological evaluation of new pyrazolo[5,1-c] [1,2,4]benzotriazine 5-oxide 3- and 8-disubstituted: high affinity ligands endowed with inverse-agonist pharmacological efficacy.
    Guerrini G; Costanzo A; Ciciani G; Bruni F; Selleri S; Costagli C; Besnard F; Costa B; Martini C; De Siena G; Malmberg-Aiello P
    Bioorg Med Chem; 2006 Feb; 14(3):758-75. PubMed ID: 16214350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of 7-(2-dimethylaminovinyl) derivatives of pyrazolo[1,5-a] pyrimidines, as precursors of new tricyclic series. Binding studies of BDZ receptor.
    Bruni F; Costanzo A; Selleri S; Guerrini G; Giusti L; Martini C; Lucacchini A
    Farmaco; 1993 Feb; 48(2):309-19. PubMed ID: 8388217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tricyclic heteroaromatic systems: [1]benzopyrano-pyrazol-4-ones as benzodiazepine receptor ligands.
    Colotta V; Cecchi L; Melani F; Filacchioni G; Martini C; Gelli S; Lucacchini A
    J Pharm Sci; 1991 Mar; 80(3):276-9. PubMed ID: 1646879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new class of pyrazolo[5,1-c][1,2,4]triazines as γ-aminobutyric type A (GABA
    Guerrini G; Ciciani G; Daniele S; Martini C; Costagli C; Guarino C; Selleri S
    Bioorg Med Chem; 2018 May; 26(9):2475-2487. PubMed ID: 29650463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel 3-iodo-8-ethoxypyrazolo[5,1-c][1,2,4]benzotriazine 5-oxide as promising lead for design of alpha5-inverse agonist useful tools for therapy of mnemonic damage.
    Guerrini G; Ciciani G; Cambi G; Bruni F; Selleri S; Besnard F; Montali M; Martini C; Ghelardini C; Galeotti N; Costanzo A
    Bioorg Med Chem; 2007 Apr; 15(7):2573-86. PubMed ID: 17306981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tricyclic heteroaromatic systems pyrazolo[1,5-a]quinoxalines: synthesis and benzodiazepine receptor activity.
    Colotta V; Cecchi L; Catarzi D; Conti G; Filacchioni G; Martini C; Giusti L; Lucacchini A
    Farmaco; 1993 Aug; 48(8):1051-63. PubMed ID: 8216668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel 3-aroylpyrazolo[5,1-c][1,2,4]benzotriazine 5-oxides 8-substituted, ligands at GABAA/benzodiazepine receptor complex: synthesis, pharmacological and molecular modeling studies.
    Guerrini G; Ciciani G; Cambi G; Bruni F; Selleri S; Melani F; Montali M; Martini C; Ghelardini C; Norcini M; Costanzo A
    Bioorg Med Chem; 2008 Apr; 16(8):4471-89. PubMed ID: 18325771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pyrazolo[4,5-c]quinolines. 2. Synthesis and specific inhibition of benzodiazepine receptor binding.
    Melani F; Cecchi L; Palazzino G; Filacchioni G; Martini C; Pennacchi E; Lucacchini A
    J Med Chem; 1986 Feb; 29(2):291-5. PubMed ID: 3005571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Geometrically constrained analogues of N-benzylindolylglyoxylylamides: [1, 2, 4]triazino[4, 3-a]benzimidazol-4(10H)-one derivatives as potential new ligands at the benzodiazepine receptor.
    Primofiore G; Da Settimo F; Taliani S; Marini AM; Simorini F; Novellino E; Greco G; Trincavelli L; Martini C
    Arch Pharm (Weinheim); 2003 Sep; 336(9):413-21. PubMed ID: 14528489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of novel condensed triazine derivatives with central and peripheral type benzodiazepine receptors: synthesis, in vitro pharmacology and modelling.
    Szárics E; Riedl Z; Nyikos L; Hajós G; Kardos J
    Eur J Med Chem; 2006 Apr; 41(4):445-56. PubMed ID: 16530296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and binding study on pyrazolo[4,5-c] [1,8]naphthyridines.
    Cecchi L; Colotta V; Filacchioni G; Melani F; Palazzino G; Galli A
    Farmaco Sci; 1987 Sep; 42(9):671-80. PubMed ID: 2826226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel anellated pyrazoloquinolin-3-ones: synthesis and in vitro BZR activity.
    Ferlin MG; Chiarelotto G; Dall'Acqua S; Maciocco E; Mascia MP; Pisu MG; Biggio G
    Bioorg Med Chem; 2005 May; 13(10):3531-41. PubMed ID: 15848766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Substituted 1,2,3-triazolo[1,5-a]quinazolines: synthesis and binding to benzodiazepine and adenosine receptors.
    Bertelli L; Biagi G; Giorgi I; Livi O; Manera C; Scartoni V; Lucacchini A; Giannaccini G; Barili PL
    Eur J Med Chem; 2000 Mar; 35(3):333-41. PubMed ID: 10785559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pyrazolo [4,3-c] quinolines synthesis and specific inhibition of benzodiazepine receptor binding (Note I).
    Savini L; Massarelli P; Pellerano C; Fiorini I; Bruni G; Romeo MR
    Farmaco; 1993 Jan; 48(1):65-76. PubMed ID: 8384455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, in vivo evaluation, and molecular modeling studies of new pyrazolo[5,1-c][1,2,4]benzotriazine 5-oxide derivatives. Identification of a bifunctional hydrogen bond area related to the inverse agonism.
    Guerrini G; Ciciani G; Cambi G; Bruni F; Selleri S; Guarino C; Melani F; Montali M; Martini C; Ghelardini C; Norcini M; Costanzo A
    J Med Chem; 2009 Aug; 52(15):4668-82. PubMed ID: 19591485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dipyrazolo[5,4-b:3',4'-d]pyridines. Synthesis, inhibition of benzodiazepine receptor binding and structure-activity relationships.
    Melani F; Cecchi L; Colotta V; Filacchioni G; Martini C; Giannaccini G; Lucacchini A
    Farmaco; 1989 Jun; 44(6):585-94. PubMed ID: 2553037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.